Company news
Weihai Baihe Biology Technological Co., Ltd. Class A (SSE:603102) news
Weihai Baihe Biology Technological Co., Ltd. Class A news releases on 6ix. Latest, Sep 30, 2026: (603102)"WEIHAI BAIHE BIOLOGY TECHNOLOGICAL CO.…
Press releases & updates
(603102)"WEIHAI BAIHE BIOLOGY TECHNOLOGICAL CO., LTD."Self-inspection Report on Trading in the Company's Shares by Insiders in Relation to the 2026 Restricted Share Incentive Plan
September 29, 2026
"WEIHAI BAIHE BIOLOGY TECHNOLOGICAL CO., LTD."Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
September 29, 2026
"WEIHAI BAIHE BIOLOGY TECHNOLOGICAL CO., LTD."Review Opinion and Statement on the Public Disclosure of the List of Participants under the 2026 Restricted Share Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of Directors
September 23, 2026
"WEIHAI BAIHE BIOLOGY TECHNOLOGICAL CO., LTD."Announcement on Summary of 2026 Restricted Share Incentive Plan (Draft)
September 11, 2026
"WEIHAI BAIHE BIOLOGY TECHNOLOGICAL CO., LTD."Announcement on Convening the 2026 Semi-annual Performance Briefing
September 3, 2026
"WEIHAI BAIHE BIOLOGY TECHNOLOGICAL CO., LTD."Announcement on the Share Reduction Plan of a Director
August 21, 2026
"WEIHAI BAIHE BIOLOGY TECHNOLOGICAL CO., LTD."Announcement on Implementation of Dividend Distribution for 2025
August 20, 2026
"WEIHAI BAIHE BIOLOGY TECHNOLOGICAL CO., LTD."Semi-annual Report for 2026
August 9, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
June 29, 2026
Announcement on Convening the 2025 Annual Performance Briefing
June 2, 2026
Notice on Convening the 2025 Annual General Meeting
May 26, 2026
Announcement on Evaluation Report on "Corporate Value and Return Enhancement" Special Action Plan 2025 and "Corporate Value and Return Enhancement" Action Plan 2026
April 29, 2026
Announcement on Main Operating Data for Q1 2026
April 15, 2026
Announcement on Change of Sponsor Representative
April 8, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
February 27, 2026
Announcement on Resolutions of the 16th Meeting of the 4th Board of Directors
February 4, 2026
Indicative Announcement on Postponing Term Change of the Board of Directors
January 8, 2026
Announcement on Re-signing Tripartite Supervision Agreement over Deposit in Special Account of Raised Funds
December 11, 2025
Announcement on Convening the Q3 2025 Performance Briefing
December 3, 2025
Announcement on Postponing Some Investment Projects Financed by Raised Funds
December 1, 2025
Report for Q3 2025
October 29, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
September 26, 2025
2025 Semi-annual Report
August 29, 2025
Announcement on Completion of Transfer of Acquired Overseas Company Equity
August 25, 2025
Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering
August 11, 2025
Announcement on Implementation of Dividend Distribution for 2024
July 29, 2025
Announcement on Adjusting the Total Profit Distribution in 2024
July 18, 2025
Announcement on Results of Shareholding Reduction by Director
July 16, 2025
Announcement on Share Repurchase Reaching 1%, Implementation Result of Shares Repurchase and Share Changes
July 15, 2025
Announcement on Adjusting Price Ceiling for Share Repurchase
July 14, 2025
Announcement on Progress in Repurchasing Shares through Call Auction
July 1, 2025
Announcement on Resolution of the 2024 Annual General Meeting
June 6, 2025
Announcement on Convening the 2024 Annual Performance Briefing
June 3, 2025
Announcement on Share Reduction Plan for Directors
May 21, 2025
Announcement on Abnormal Fluctuations in Stock Trading
May 19, 2025
2024 Annual Report
April 14, 2025
Announcement on Initially Repurchasing Shares through Call Auction
March 10, 2025
Announcement on Change of Signatory Certified Public Accountant and Project Quality Control Reviewer
March 7, 2025
Announcement on Failure to Implement Repurchase with Half of the Repurchase Period Expired
February 10, 2025
Announcement on Listing and Circulation of Some Restricted Stocks in Initial Public Offering
January 20, 2025
Announcement on Closing Some Investment Projects Financed by Raised Funds and Canceling Special Accounts for Raised Funds
December 30, 2024
Announcement on Convening the Q3 2024 Performance Briefing
November 19, 2024
Report for Q3 2024
October 24, 2024
Announcement on Convening Semi-annual Performance Briefing in 2024
September 2, 2024
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2024
August 26, 2024
Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders without Sales Limit Concerning Share Repurchase
August 14, 2024
Notice on the 1st Extraordinary General Meeting in 2024
August 8, 2024
Announcement on Extension of Some Fundraising Projects
July 18, 2024
Announcement on Convening 2023 Annual Performance Meeting
May 28, 2024
Announcement on Implementation of Dividend Distribution of 2023
May 27, 2024